Delivery Order SPE2DB20D2104-SPE2DB25FMZFP
- Not listed
- The Defense Logistics Agency awarded a $13,432.45 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, a diabetes medication. The contract, executed on July 23, 2025, with an ultimate completion date of July 24, 2025, utilizes firm fixed pricing under a non-competitive set-aside delivery order structure. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order functions as a...
- The Defense Logistics Agency awarded a delivery order valued at $10,956.72 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a pharmaceutical product used in diabetes management. The contract is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and was awarded on August 15, 2025. No set-aside designation was utilized for this procurement, indicating the award was made through open competition. The vendor is performing the work from its...
- The Defense Logistics Agency awarded a $13,119.26 delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, a pharmaceutical product used in diabetes management. This contract, awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was made competitively and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $5,669.66 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes medication, with an ultimate completion date of July 25, 2025. This contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $14,395.43 to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, an oral diabetes medication. The contract was competitively awarded on July 21, 2025, with a completion date of July 22, 2025, using firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order. This delivery order is issued...
- The Defense Logistics Agency awarded a $24,339.12 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded to the prime contractor. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) valued at $18,509.94 under a firm fixed-price contract. This is a non-set-aside competitive award executed at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.71 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. This non-competitive, firm fixed-price delivery order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a routine pharmaceutical supply delivery under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $21,295.85. This non-competitive, competitively awarded delivery order is scheduled for completion by August 21, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $8,420.29 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. The order was competitively awarded on September 4, 2025, with a firm fixed price and an ultimate completion date of September 5, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. This delivery order is issued under...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMZFPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,274.92 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes management medication. This non-competitive delivery order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed price transaction fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The award is classified as a child contract, indicating it derives from a larger indefinite delivery contract (IDC) vehicle. This delivery order is executed under AmerisourceBergen Drug Corp's $999,999,999.00 Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a global pharmaceutical support vehicle. The parent IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains significant federal procurement capabilities and consistently demonstrates competitive viability across DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 9/2/25 |